United Kingdom· GB-APID-36109811000001105
Nuwiq 3,000unit powder and solvent for solution for injection vials
A simoctocog alfa product containing simoctocog alfa, registered in United Kingdom by Octapharma Ltd. The same ATC class is registered in 2 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Simoctocog alfa is registered in 2 of 19 countries.
Countries holding a registration under ATC B02BD44 (simoctocog alfa), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 1 of them publish a price we can compare per daily dose
Simoctocog alfa · ATC B02BD44
2 / 19 countries
- Franceprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Simoctocog alfa
- Manufacturer
- Octapharma Ltd
- Country
- United Kingdom (GB)
- ATC code
- B02BD44
- ATC class
- Simoctocog alfa
- Defined daily dose
- 1 TSD, E
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5060237671188
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Simoctocog alfa in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumNuwiq 1000 IUOctapharma
- FinlandNuwiqOctapharma AB
- IrelandNuwiq 1000 IU powder and solvent for solution for injectionOctapharma AB
- NetherlandsNuwiq 1000 IE poeder en oplosmiddel voor oplossing voor injectieOctapharma AB
- PolandNuwiqOctapharma AB
- FranceNUWIQ 1000 UI, poudre et solvant pour solution injectableOCTAPHARMA (SUEDE)
- IcelandNuwiqOctapharma AB
- CzechiaNUWIQOctapharma AB, Stockholm
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Nuwiq
- Liechtenstein · Nuwiq
- Norway · Nuwiq
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f4a458c2-73a8-4a50-bd8f-b4942b045f00 GET /v1/drugs/f4a458c2-73a8-4a50-bd8f-b4942b045f00?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "36109811000001105",
"desc": "Nuwiq 3,000unit powder and solvent for solution for injection vials (Octapharma Ltd)",
"form": "Powder and solvent for solution for injection",
"vpid": "36109611000001106",
"source": "dmd",
"vtm_id": "28009711000001101",
"strength": "3000 unit",
"substance": "Simoctocog alfa",
"ingredient": "Simoctocog alfa",
"supplier_code": "2080601000001107"
}See everything about simoctocog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.